(R)-5-(2-((Tert-Butyldimethylsilyl)Oxy)Ethyl)-4-Chloro-6,7-Dihydro-5H-Cyclopenta[4,5]Thieno[2,3-D]Pyrimidine synthesis
- Product Name:(R)-5-(2-((Tert-Butyldimethylsilyl)Oxy)Ethyl)-4-Chloro-6,7-Dihydro-5H-Cyclopenta[4,5]Thieno[2,3-D]Pyrimidine
- CAS Number:1388894-05-0
- Molecular formula:C17H25ClN2OSSi
- Molecular Weight:369
Yield: 96%
Reaction Conditions:
with 1H-imidazole in N,N-dimethyl-formamide at 20; for 2 h;Inert atmosphere;
Steps:
25
Example 25: Synthesis of Intermediate Hb.Fb Hb (21b)[00627] Intermediate Fb (1.3 g, 5.10 mmol, 1.00 equiv) was treated with imidazole (500 mg, 7.44 mmol, 1.40 equiv) and TBDMSCl (920 mg, 6.10 mmol, 1.20 equiv) in distilled DMF (10 mL) for 2 h at room temperature under nitrogen. The reaction was then quenched with water and extracted with ethyl acetate (3 x 50 mL). The combined organic layers were washed with brine and dried over anhydrous sodium sulfate. After filtration and concentration under reduced pressure, the residue was loaded onto a silica gel column with ethyl acetate/petroleum ether (1 :5) and purified to give (-?R)-3-[2-[(½ri-butyldimethylsilyl)oxy]ethyl]-12-chloro-7-thia-9, l l- diazatricyclo[6.4.0.0[2,6]]dodeca-l(8),2(6),9,l l-tetraene (Hb, 1.8 g, 96%) as a yellow oil.
References:
NIMBUS IRIS, INC.;ROMERO, Donna L.;WESSEL, Matthew David;ROBINSON, Shaughnessy;GREENWOOD, Jeremy Robert;WATTS, Karl Shawn;FRYE, Leah Lynn;HARRIMAN, Geraldine C.;CORIN, Alan Franklin;MASSE, Craig WO2012/97013, 2012, A1 Location in patent:Page/Page column 277
20826-94-2
167 suppliers
$26.00/1g
1388894-05-0
9 suppliers
inquiry
1029689-54-0
7 suppliers
inquiry
1388894-05-0
9 suppliers
inquiry
1388893-76-2
8 suppliers
inquiry
1388894-05-0
9 suppliers
inquiry
1388893-77-3
9 suppliers
inquiry
1388894-05-0
9 suppliers
inquiry